- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | CatalYm Announces New Chief Financial Officer Peter Garcia | ||
| Di | Syntax Bio Pairs With Mayo Clinic on Stem-Cell Pancreatic Cell Therapies for Type 1 Diabetes | ||
| Di | Syntis Bio Taps Matthew Dallas as CFO | ||
| Di | GSK Agrees to Acquire Nuvalent for $10.6B | ||
| Mo | AdvanCell Names New CTO and CSO, Expanding Executive Leadership Team | ||
| Mo | Shilpa Medicare, Gate2Brain Partner to Advance First-in-Class Brain Cancer Therapy | ||
| Mo | J&J Agrees to Acquire Firefly Bio for $1B | ||
| Mo | Pfizer's Hympavzi Gets FDA Approval for Expanded Indication | ||
| Mo | Roche Strikes $2.3B Nurix Deal for BTK Degrader | ||
| Mo | Stevanato Group Introduces New Proprietary Pen Injector Platform | ||
| Mo | Barentz Opens New Office in Chesterbrook, PA | ||
| Mo | Apnimed Appoints Kevin Lind as CEO | ||
| Mo | Incyte Agrees to Acquire Vega Therapeutics for $1.25B | ||
| Fr | Sanofi Inks Five-Year Pact to License Owkin's AI Scientist K Pro for Next-Gen Biopharma Agents | ||
| Fr | WuXi Biologics Tops Out Modular Drug Product Facility in Singapore | ||
| Fr | Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines | ||
| Do | Haga Bioscience Closes $2.3M Funding Round to Commercialize Spatial Biology Tech | ||
| Do | Massive Bio, Optellum Partner on Early Detection, Clinical Trial Access for Lung Cancer | ||
| Do | Travere Therapeutics, Everest Medicines Partner to Advance Civorebrutinib | ||
| Do | Lonza, Stipple Bio Sign ADC Licensing Deal | ||
| Do | Pfizer to Leverage Chai Discovery's AI Platform | ||
| Do | Thermo Fisher Introduces M Series Centrifuges | ||
| Do | Natera, CytoDyn Partner in Colorectal Cancer Study | ||
| Do | Veranova Appoints Dr. Bob Huang as VP & GM of West Deptford, NJ Facility | ||
| Do | SCHOTT Pharma Expands Vial Production in Lebanon, PA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.